In patients with COPD, transcatheter aortic valve replacement was associated with fewer respiratory-related complications than surgical aortic valve replacement.
Major adverse cardiovascular events were not reduced in patients with acute coronary syndrome undergoing planned percutaneous coronary intervention when given 2 loading doses of atorvastatin.
Although rare, delayed coronary obstruction after transcatheter aortic valve replacement was tied to a 50% in-hospital mortality rate.
Aim of study was to determine whether treatment with percutaneous coronary intervention or coronary artery bypass grafting leads to improved outcomes in patients with diabetes, coronary artery disease, and left ventricular dysfunction.
Rapid deployment valve use linked to increased rates of pacemaker implantation and disabling stroke, but not mortality.
Overall, 24.4% of instances of medical advice regarding implanted cardiac defibrillators were considered inappropriate for most patients.
Patients with pulmonary hypertension have a high risk for adverse events during and following cardiac catheterization, but high case volume may help ameliorate this risk.
The smartphone heart rate monitoring application had higher diagnostic accuracy compared with standard physical examination for determining ulnar artery patency prior to radial access.
Genotype-guided therapy improved outcomes in patients who were CYP2C19 intermediate and poor metabolizers.
Clinically relevant and subclinical structural valve degeneration seen in 6.6% and 30.1%, respectively.
For patients post coronary artery bypass graft surgery, new-onset postoperative atrial fibrillation is associated with lower long-term thromboembolic risk than that seen among patients with nonvalvular atrial fibrillation.
Patent foramen ovale closure resulted in a lower recurrence of stroke in patients with cryptogenic stroke and high-risk PFO characteristics.
A magnetically levitated centrifugal-flow pump was superior to a mechanical-bearing axial continuous-flow pump in patients with advanced heart failure.
The FDA has approved a new size of the Masters Series Mechanical Heart Valve with Hemodynamic Plus Sewing Cuff for use in newborn patients with heart defects.
Abnormal glucose metabolism may be present in patients with undetected diabetes after percutaneous coronary intervention.
A shared decision-making program between patients with end-stage heart failure being considered for destination therapy left ventricular assist device and their caregivers was associated with improvement in patient knowledge.
In patients with diabetes, multivessel coronary artery disease, and left ventricular dysfunction, coronary artery bypass grafting was associated with a reduction in major adverse cardiac and cerebrovascular events and mortality.
There were no significant differences for the observed 3-year rates of target vessel failure for different types of drug-eluting stents in patients with left main coronary artery disease.
A quality improvement intervention can reduce inefficiencies in the cardiac catheterization lab.
Preoperatively diagnosed patent foramen ovale is associated with increased risk for perioperative ischemic stroke in adults undergoing noncardiac surgery.
Percutaneous closure of patent foramen ovale is not associated with a reduction in migraine headaches in patients with and without aura.
Compliance with guideline-directed medical therapy is low, but remains higher in PCI than in CABG.
The presence of depressive symptoms among older adults undergoing TAVR or SAVR increases the risk of mortality.
Distance from cardiac catheterization center independently predicts survival in ACS with cardiogenic shock.
A 35-year-old pregnant woman presents to the emergency department with progressive dyspnea and palpitations that have worsened during the last 3 weeks.
Catheter ablation was associated with a significant reduction in a composite end point of death from any cause or hospitalization for worsening heart failure in patients with atrial fibrillation.
Percutaneous coronary intervention is associated with increased rates of adverse outcomes compared with CABG in patients with 3-vessel CAD.
Clinical practice guidelines for anticoagulation therapy for cardiopulmonary bypass have been developed.
Percutaneous patent foramen ovale closure is superior to medical treatment alone in preventing recurrent strokeJanuary 23, 2018
Patent foramen ovale (PFO) closure was superior to medical treatment alone in preventing transient ischemic attack and recurrent stroke. However, PFO closure also raised the risk for atrial fibrillation or atrial flutter in people with PFO and cryptogenic stroke.
Thrombectomy performed between 6 and 24 hours after onset of acute stroke in patients with a mismatch between stroke symptoms and infarct volume results in better disability outcomes compared to standard care alone.
The Cardiology Advisor Articles
- The Mounting Evidence Against Electronic Cigarette Use
- Entresto Significantly Improves Physical, Social Activity in Heart Failure Patients
- Nonpsychotic Cannabinoids in Hypertension: Benefits and Harms
- ACC and AHA Release 2018 Quality Measures for Cardiac Rehabilitation
- Unique Vit B3 Formulation May Improve Blood Pressure, CV Health
- AHA: Assessment and Promotion of Physical Activity for CVD Prevention
- Benefits of Targeted Pharmacologic Therapy in PAH and Distal CTEPH
- Transcatheter vs Surgical Aortic Valve Replacement in COPD
- Breathing New Life Into COPD and Asthma Therapy With Statins
- ACP: Position Paper Recommends Solutions to Close Gender Equity Gap